Neon Therapeutics Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
71
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$70.6M
Neon Therapeutics General Information
Description
Developer of neoantigen-targeted therapies designed to treat cancer by directing the immune system towards neoantigens. The company specializes in identifying patient-derived tumor-specific neoantigens to create individualized vaccines and autologous T-cell therapies, thereby enabling targeted treatment approaches that harness the immune system to fight cancer.
Contact Information
Website
www.neontherapeutics.comCorporate Office
- 40 Erie Street
- Suite 110
- Cambridge, MA 02139
- United States
Corporate Office
- 40 Erie Street
- Suite 110
- Cambridge, MA 02139
- United States
Neon Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 06-May-2020 | $70.6M | Completed | Generating Revenue | ||
| 3. IPO | 27-Jun-2018 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 05-Dec-2017 | $106M | $161M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 01-Oct-2015 | $55M | $55M | Completed | Startup |
Neon Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Neon Therapeutics Comparisons
Industry
Financing
Details
Neon Therapeutics Competitors (49)
One of Neon Therapeutics’s 49 competitors is Arno Therapeutics, a Formerly VC-backed company based in Flemington, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Arno Therapeutics | Formerly VC-backed | Flemington, NJ | ||||
| OncoResponse | Venture Capital-Backed | Houston, TX | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Cellaion | Formerly VC-backed | Mont-Saint-Guibert, Belgium | ||||
| NGM Biopharmaceuticals | Private Equity-Backed | South San Francisco, CA |
Neon Therapeutics Signals
Neon Therapeutics Former Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Access Industries | PE/Buyout | Minority | ||
| ArrowMark Partners | Asset Manager | Minority | ||
| Casdin Capital | Venture Capital | Minority | ||
| Clal Biotechnology Industries | Venture Capital | Minority | ||
| Fidelity Management & Research Company | Asset Manager | Minority |
Neon Therapeutics ESG
Risk Overview
Risk Rating
Updated January, 31, 2026
22.15 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,999
Rank
Percentile
Pharmaceuticals
Industry
of 952
Rank
Percentile
Biotechnology
Subindustry
of 444
Rank
Percentile
Neon Therapeutics FAQs
-
When was Neon Therapeutics founded?
Neon Therapeutics was founded in 2013.
-
Where is Neon Therapeutics headquartered?
Neon Therapeutics is headquartered in Cambridge, MA.
-
What is the size of Neon Therapeutics?
Neon Therapeutics has 71 total employees.
-
What industry is Neon Therapeutics in?
Neon Therapeutics’s primary industry is Drug Discovery.
-
Is Neon Therapeutics a private or public company?
Neon Therapeutics is a Private company.
-
What is the current valuation of Neon Therapeutics?
The current valuation of Neon Therapeutics is .
-
What is Neon Therapeutics’s current revenue?
The current revenue for Neon Therapeutics is .
-
How much funding has Neon Therapeutics raised over time?
Neon Therapeutics has raised $261M.
-
Who are Neon Therapeutics’s investors?
Access Industries, ArrowMark Partners, Casdin Capital, Clal Biotechnology Industries, and Fidelity Management & Research Company are 5 of 13 investors who have invested in Neon Therapeutics.
-
Who are Neon Therapeutics’s competitors?
Arno Therapeutics, OncoResponse, Inovio Pharmaceuticals, Cellaion, and NGM Biopharmaceuticals are some of the 49 competitors of Neon Therapeutics.
-
When was Neon Therapeutics acquired?
Neon Therapeutics was acquired on 06-May-2020.
-
Who acquired Neon Therapeutics?
Neon Therapeutics was acquired by BioNTech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process